Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The RDM Annual Symposium 2017 will take place on 6 March 2017 at the Saïd Business School. This event is an excellent opportunity to bring all members of the department together to celebrate and share the cutting edge research being undertaken within RDM.

Picture of a lecturer gesturing.

We are pleased to announce that our keynote speaker will be Dr Robert Balaban, Chief of the Laboratory of Cardiac Energetics and Scientific Director of the National Heart, Lung, and Blood Institute at the NIH.

Call for Posters

As part of the day we will have a poster session where students and postdocs/fellows, based in research groups within RDM, have the opportunity to present their research. We would like to invite you to submit an abstract to present a poster at the symposium.

As we are limited in the number of posters we can display (maximum 50), we would suggest that no more than 2-3 abstracts are submitted per research group. We will review all abstracts that are submitted to us and the best abstracts will be selected for poster presentation. There will be a prize for the best student poster and the best postdoc/fellow (non-student) poster.

The abstract submission deadline is noon on 10 February 2017. More information and guidelines for submitting an abstract are available on the website. Any questions should be directed to Serena Briant.

Everyone in RDM is invited and encouraged to attend the symposium. Attendance is free and event registration is now open.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.